ORAMED PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Issued from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Oramed Pharmaceuticals Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2011 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 40.6M shares, a 1.02% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 40.6M +410K +1.02% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 40.5M +549K +1.37% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 40.3M +775K +1.96% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 40.3M +1.17M +2.99% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 40.2M +1.66M +4.29% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 40M +1.41M +3.65% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 39.6M +1.41M +3.68% Dec 31, 2022 10-K 2024-03-06
Q3 2022 39.1M +3.82M +10.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 38.6M +8.04M +26.3% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 38.6M +10.3M +36.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 38.2M +14.3M +60.3% Dec 31, 2021 10-K 2023-03-06
Q3 2021 35.3M +11.6M +49.1% Aug 31, 2021 10-QT 2022-03-30
Q2 2021 30.5M +7.25M +31.1% May 31, 2021 10-Q 2021-07-14
Q1 2021 28.3M +5.2M +22.5% Feb 28, 2021 10-Q 2021-04-13
Q4 2020 23.8M +6.41M +36.8% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 23.7M +6.29M +36.2% Aug 31, 2020 10-K 2021-11-24
Q2 2020 23.3M +5.89M +33.9% May 31, 2020 10-Q 2020-07-07
Q1 2020 23.1M +5.71M +32.9% Feb 29, 2020 10-Q 2020-04-06
Q4 2019 17.4M +22.3K +0.13% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 17.4M +13.5K +0.08% Aug 31, 2019 10-K 2020-11-24
Q2 2019 17.4M +2.91M +20.1% May 31, 2019 10-Q 2019-07-10
Q1 2019 17.4M +2.97M +20.7% Feb 28, 2019 10-Q 2019-04-10
Q4 2018 17.4M +3.07M +21.5% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 17.4M +3.7M +27.1% Aug 31, 2018 10-K 2019-11-27
Q2 2018 14.5M +1.15M +8.63% May 31, 2018 10-Q 2018-07-12
Q1 2018 14.4M +1.11M +8.38% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 14.3M +1.04M +7.84% Nov 30, 2017 10-Q 2018-01-11
Q3 2017 13.7M +485K +3.68% Aug 31, 2017 10-K 2018-11-28
Q2 2017 13.3M +188K +1.43% May 31, 2017 10-Q 2017-07-06
Q1 2017 13.3M +182K +1.39% Feb 28, 2017 10-Q 2017-04-05
Q4 2016 13.3M +1.67M +14.4% Nov 30, 2016 10-Q 2017-01-11
Q3 2016 13.2M +1.62M +14% Aug 31, 2016 10-K 2017-11-29
Q2 2016 13.1M +2.29M +21.2% May 31, 2016 10-Q 2016-07-06
Q1 2016 13.1M +2.29M +21.2% Feb 29, 2016 10-Q 2016-04-06
Q4 2015 11.6M +790K +7.31% Nov 30, 2015 10-Q 2016-01-13
Q3 2015 11.6M +1.46M +14.5% Aug 31, 2015 10-K 2016-11-25
Q2 2015 10.8M +881K +8.85% May 31, 2015 10-Q 2015-07-01
Q1 2015 10.8M +1.04M +10.7% Feb 28, 2015 10-Q 2015-04-03
Q4 2014 10.8M +2.86M +36% Nov 30, 2014 10-Q 2015-01-08
Q3 2014 10.1M +2.16M +27.3% Aug 31, 2014 10-K 2015-11-25
Q2 2014 9.96M +2.73M +37.8% May 31, 2014 10-Q 2014-07-14
Q1 2014 9.78M +2.55M +35.4% Feb 28, 2014 10-Q 2014-04-10
Q4 2013 7.95M +748K +10.4% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 7.94M +7.87M +11604% Aug 31, 2013 10-K 2014-11-14
Q2 2013 7.23M -63.2M -89.7% May 31, 2013 10-Q 2013-07-17
Q1 2013 7.22M -63M -89.7% Feb 28, 2013 10-Q 2013-04-11
Q4 2012 7.2M -62.9M -89.7% Jan 10, 2013 10-Q 2014-04-10
Q3 2012 67.8K -70M -99.9% Sep 30, 2012 10-K 2012-12-12
Q2 2012 70.4M May 31, 2012 10-Q 2012-07-12
Q1 2012 70.2M Feb 29, 2012 10-Q 2012-04-04
Q4 2011 70.1M Nov 30, 2011 10-Q 2012-01-12
Q3 2011 70.1M Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.